J 2016

First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples

HEATH, Ester, Marjeta CESEN, Noelia NEGREIRA, Miren Lopez DE ALDA, Laura FERRANDO-CLIMENT et. al.

Základní údaje

Originální název

First inter-laboratory comparison exercise for the determination of anticancer drugs in aqueous samples

Autoři

HEATH, Ester (705 Slovinsko), Marjeta CESEN (705 Slovinsko), Noelia NEGREIRA (724 Španělsko), Miren Lopez DE ALDA (724 Španělsko), Laura FERRANDO-CLIMENT (724 Španělsko), Lucie BLÁHOVÁ (203 Česká republika, garant, domácí), Tung Viet NGUYEN (702 Singapur), Mohamed ADAHCHOUR (528 Nizozemské království), Achim RUEBEL (276 Německo), Neville LLEWELLYN (826 Velká Británie a Severní Irsko), Janez SCANCAR (705 Slovinsko), Srdjan NOVAKOVIC (705 Slovinsko), Vesna MISLEJ (705 Slovinsko), Marjeta STRAZAR (705 Slovinsko), Damia BARCELO (724 Španělsko) a Tina KOSJEK (705 Slovinsko)

Vydání

Environmental Science and Pollution Research, Landsberg, Germany, Ecomed, 2016, 0944-1344

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30304 Public and environmental health

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.741

Kód RIV

RIV/00216224:14310/16:00093523

Organizační jednotka

Přírodovědecká fakulta

UT WoS

000380369900002

Klíčová slova anglicky

Inter-laboratory study; Cytostatic; Pharmaceutical; Surfacewater; Wastewater; Hospital effluent

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 13. 3. 2020 11:22, Mgr. Marie Šípková, DiS.

Anotace

V originále

The results of an inter-laboratory comparison exercise to determine cytostatic anticancer drug residues in surface water, hospital wastewater and wastewater treatment plant effluent are reported. To obtain a critical number of participants, an invitation was sent out to potential laboratories identified to have the necessary knowledge and instrumentation. Nine laboratories worldwide confirmed their participation in the exercise. The compounds selected included cyclophosphamide, ifosfamide, 5-fluorouracil, gemcitabine, etoposide, methotrexate and cisplatinum. Samples of spiked waste (hospital and wastewater treatment plant effluent) and surface water, and additional non-spiked hospital wastewater, were prepared by the organising laboratory (JoA3/4ef Stefan Institute) and sent out to each participant partner for analysis. All analytical methods included solid phase extraction (SPE) and the use of surrogate/internal standards for quantification. Chemical analysis was performed using either liquid or gas chromatography mass (MS) or tandem mass (MS/MS) spectrometry. Cisplatinum was determined using inductively coupled plasma mass spectrometry (ICP-MS). A required minimum contribution of five laboratories meant that only cyclophosphamide, ifosfamide, methotrexate and etoposide could be included in the statistical evaluation. z-score and Q test revealed 3 and 4 outliers using classical and robust approach, respectively. The smallest absolute differences between the spiked values and the measured values were observed in the surface water matrix. The highest within-laboratory repeatability was observed for methotrexate in all three matrices (CV a parts per thousand currency signaEuro parts per thousand 12 %). Overall, inter-laboratory reproducibility was poor for all compounds and matrices (CV 27-143 %) with the only exception being methotrexate measured in the spiked hospital wastewater (CV = 8 %). Random and total errors were identified by means of Youden plots.

Návaznosti

603437, interní kód MU
Název: SOLUTIONS - Solutions for present and future emerging pollutants in land and water resources management (Akronym: SOLUTIONS)
Investor: Evropská unie, SOLUTIONS - Solutions for present and future emerging pollutants in land and water resources management, Spolupráce